Sectoral Asset Management’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-379,443
Closed -$9.71M 128
2023
Q2
$9.71M Buy
379,443
+13,000
+4% +$336K 1.62% 17
2023
Q1
$9.23M Buy
366,443
+186,519
+104% +$4.38M 1.77% 16
2022
Q4
$4.14M Sell
179,924
-63,750
-26% -$1.47M 0.8% 53
2022
Q3
$5.38M Sell
243,674
-133,004
-35% -$2.57M 1.06% 41
2022
Q2
$5.4M Buy
376,678
+165,654
+79% +$2.79M 1.09% 39
2022
Q1
$3.99M Sell
211,024
-20,000
-9% -$389K 0.71% 56
2021
Q4
$4.31M Sell
231,024
-309,998
-57% -$6.4M 0.65% 62
2021
Q3
$14.6M Buy
541,022
+300,257
+125% +$8.26M 1.21% 25
2021
Q2
$7.53M Buy
+240,765
New +$7.66M 0.61% 71

Other funds holding TMCI

Sectoral Asset Management's TMCI Position: Q3 2023 in Review

Sectoral Asset Management sold out of Treace Medical Concepts (TMCI) in Q3 2023, closing a stake of 379,443 shares — an estimated $9.71M sold.

Sectoral Asset Management first reported a position in TMCI in Q2 2021 and held it in 9 quarters. The position peaked at $14.6M in Q3 2021. 123 funds tracked by Wall St. Rank hold TMCI as of Q3 2023.

  • Sectoral Asset Management reported no remaining Treace Medical Concepts position as of Q3 2023 after selling out during the quarter.
  • Sectoral Asset Management sold 379,443 Treace Medical Concepts shares in Q3 2023, an estimated $9.71M.
  • Sectoral Asset Management first reported a position in Treace Medical Concepts in Q2 2021 and held it in 9 quarters.
  • Sectoral Asset Management's Treace Medical Concepts position peaked at $14.6M in Q3 2021.
  • 123 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2023.

Based on Sectoral Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.